Dr Shaaban is a specialist breast pathologist at Queen Elizabeth Hospital Birmingham and Honorary Senior Lecturer at the University of Birmingham. She trained in anatomic pathology in Liverpool, Birmingham and Leeds. She completed her PhD in molecular pathology at the University of Liverpool with the late Prof John Sloane.

She has led a number of research studies and contributed to breast cancer trials as co-investigator, member of a Trial Management Group and as a central pathology reviewer. She was member of the NCRI Breast CSG for two terms and acted as chair of the Translational Subgroup of the NCRI Breast CSG for 5 years. The subgroup produced several landmark publications including guidance on improving the turnaround of HER2 testing, manufacture and reporting of tissue microarrays and handling of neoadjuvant chemotherapy cases. She published over 110 peer reviewed papers and contributed a number of book chapters including in the WHO Blue Book for Breast tumours 2019. She co-edited a textbook of molecular pathology entitled “Molecular pathology for the practising surgical pathologist and cytopathologists”

Dr Shaaban led the Cellular and Molecular Pathology initiative (CM-PATH) Workstream 2 (clinical trials). She served as member of the International Committee of The Royal College of Pathologists and is Breast screening advisor (PCA) for Public Health England in the West Midlands.

Dr Shaaban organises an annual multidisciplinary breast update course (www.breastpathologyupdate.com). She lectured on a number of UK and international courses/conferences including BDIAP, ESSO, EBBC, Pathological Society of Great Britain and Ireland meetings.